After adjustment for the factors of age, smoking, and histories of cancer and coronary heart disease, researchers found that urinary levels of melatonin was 40% lower in AMD patients compared than that of the age-and gender-matched controls.

The researchers concluded: “The significance of this result and the role of melatonin in the occurrence of AMD require further investigation.”